BVXV US09073Q1058

Bericht

Verzögert Nasdaq - 27/05 22:00:00
1.300	USD		0.00%

28.03.	BiondVax Pharmaceuticals Ltd. berichtet über die Ergebnisse für das am 31. Dezember 2021 beendete Geschäftsjahr	CI
24.03.	SEKTOR-UPDATE : Aktien aus dem Gesundheitssektor finden kurz vor Börsenschluss am Donnerstag mehr Unterstützung	MT
24.03.	SEKTOR-UPDATE : Aktien aus dem Gesundheitssektor gewinnen am Donnerstag an Zugkraft	MT

News

Analystenempfehlungen

Andere Sprachen

Pressemitteilungen

Offizielle Publikationen

Branchen-News

Nachrichten in anderen Sprachen über BIONDVAX PHARMACEUTICALS LTD.

19.05.	BiondVax to Present at H.C. Wainwright Global Investment Conference
12.05.	BiondVax Provides Update at Biomed Israel Conference and Announces Significant Progress..
09.05.	BiondVax to Present at this week's Biomed Israel Conference
12.04.	BIONDVAX PHARMACEUTICALS : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
08.04.	BIONDVAX PHARMACEUTICALS : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
05.04.	BiondVax to host a Hebrew-language analyst and investor webinar on April 6th
04.04.	BIONDVAX PHARMACEUTICALS : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
31.03.	BiondVax to host analyst and investor webinar on April 4th
28.03.	BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Bus..
28.03.	BIONDVAX PHARMACEUTICALS : Annual Report by Foreign Issuer (Form 20-F)
28.03.	BiondVax Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December..
28.03.	Certain Ordinary Share of BiondVax Pharmaceuticals Ltd. are subject to a Lock-Up Agreem..
24.03.	SECTOR UPDATE : Health Care Stocks Finding More Support Near Thursday Close
24.03.	Top Midday Gainers
24.03.	SECTOR UPDATE : Health Care Stocks Gaining Traction Thursday
24.03.	SECTOR UPDATE : Health Care
24.03.	SECTOR UPDATE : Health Care Stocks Edge Higher Premarket Thursday
24.03.	SECTOR UPDATE : Health Care
24.03.	BiondVax Pharmaceuticals Signs Research Deal in Germany for Development of Nano-Sized A..
24.03.	BiondVax signs definitive collaboration agreement for the development of a pipeline of ..
24.03.	BiondVax Pharmaceuticals Ltd. Signs Definitive Agreements with the Max Planck Society
15.03.	BiondVax Pharmaceuticals Ltd. - European Investment Bank Agrees in Principle to Extend ..
14.03.	European Investment Bank Agrees in Principle to Extend the Maturity of its Loan until D..
22.02.	BiondVax to Present at Aegis Virtual Conference
15.02.	BiondVax to Present at BIO CEO & Investor Conference
26.01.	BiondVax to Present at Edison Group's Open House Conference
26.01.	BIONDVAX PHARMACEUTICALS : to Present at Edison Group's Open House Conference
10.01.	BiondVax to Present at H.C. Wainwright Bioconnect Virtual Conference
2021	AFTER HOURS WATCH LIST SCORECARD : Bvxv, tyme
2021	BIONDVAX PHARMACEUTICALS : Former CFO of GSK's Global Vaccines Business Mr. Jay Green Join..
2021	BiondVax Announces Successful Closing of $9.8 million Follow-on Underwritten Offering o..
2021	MT NEWSWIRES AFTER HOURS WATCH LIST : Bvxv, tyme
2021	BiondVax Pharma Raises $9.8 Million from Stock Sale
2021	BiondVax Pharmaceuticals Appoints Jay Green to Board of Directors
2021	Top Premarket Gainers
2021	ADRs End Higher; Hailiang Education Up on Acquisition Proposal
2021	BIONDVAX PHARMACEUTICALS : Announces Pricing of $9.0 million Follow-on Underwritten Offeri..
2021	Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Di..
2021	Jay Green Joins BiondVax's Board of Directors
2021	Top Premarket Decliners
2021	BiondVax Pharmaceuticals Prices Offering of 3.8 Million American Depositary Shares
2021	BIONDVAX PHARMACEUTICALS : INTERIM FINANCIAL STATEMENTS - Form 6-K/A
2021	BiondVax signs definitive agreements for development and commercialization of innovativ..
2021	BIONDVAX PHARMACEUTICALS : signs definitive agreements for development and commercializati..
2021	BiondVax Pharmaceuticals Joins German Institutes to Develop COVID-19 Nanosized Antibodi..
2021	Health Care Stocks Climbing in Late Trade
2021	SECTOR UPDATE : Health Care
2021	Top Midday Gainers
2021	Health Care Stocks Retreat Pre-Bell Wednesday
2021	Top Premarket Gainers
2021	BiondVax Pharmaceuticals Working With German Institutes to Develop COVID-19 Nanosized A..
2021	BiondVax signs definitive agreements for development and commercialization of innovativ..
2021	BiondVax Signs Definitive Agreements for Development and Commercialization of Innovativ..
2021	BIONDVAX PHARMACEUTICALS : announces Third Quarter 2021 Financial Results and Provides Bus..
2021	BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update
2021	BiondVax Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine M..
2021	BiondVax Pharmaceuticals Schedules Shareholder Meeting Amid Preparations to Produce VHH..
2021	BIONDVAX PHARMACEUTICALS : Announces Notice of Annual General Meeting of Shareholders and ..
2021	BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Busi..
2021	BIONDVAX PHARMACEUTICALS : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
2021	BiondVax to Present at H.C. Wainwright 7th Annual Israel Conference
2021	NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
2021	BIONDVAX PHARMACEUTICALS : advances its growth strategy towards a new pipeline based on in..
2021	BIONDVAX PHARMACEUTICALS : Announces VHH Antibodies Collaboration With German Institutions..
2021	BIONDVAX PHARMACEUTICALS : advances its growth strategy towards a new pipeline based on in..
2021	BiondVax Advances Its Growth Strategy Towards A New Pipeline Based on Innovative VHH An..
2021	BIONDVAX PHARMACEUTICALS : Announces Second Quarter 2021 Financial Results and Provides Bu..
2021	BIONDVAX PHARMACEUTICALS : Trims Q2 Net Loss From Same Quarter in 2020
2021	BiondVax Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter Ended Jun..
2021	BIONDVAX PHARMACEUTICALS : Announces Second Quarter 2021 Financial Results and Provides Bu..
2021	BIONDVAX PHARMACEUTICALS : Announces First Quarter 2021 Financial Results and Provides Bus..
2021	BIONDVAX PHARMACEUTICALS : Announces First Quarter 2021 Financial Results and Provides Bus..
2021	Biondvax Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December..
2021	BIONDVAX PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2020 Financial Results a..
2021	Certain American Depositary Shares of BiondVax Pharmaceuticals Ltd. are subject to a Lo..

1 2 3 Weiter

Anstehende Termine für BIONDVAX PHARMACEUTICALS LTD.

01.06.22

Q1 2022 Ergebnisveröffentlichung (geplant)

Finanzkalender des Unternehmens

Anstehende Branchentermine

26.07.22	IQVIA HOLDINGS INC. : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
27.07.22	LONZA GROUP AG : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
28.07.22	SEAGEN INC. : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)
10.08.22	MODERNA, INC. : Erstes Halbjahr 2022 Ergebnisveröffentlichung (geplant)

Mehr Termine

Branche

Gesundheitspflege
	Pharmazie und Biotechnologie
		Biotechnologie und medizinische Forschung
			Biotechnologie
				Biotechnologie und medizinische Forschung - Andere